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ABSTRACT 
Lung cancer is the leading cause of cancer deaths. Early detection through low-dose computed 
tomography (CT) screening has been shown to significantly reduce mortality but suffers from a 
high false positive rate that leads to unnecessary diagnostic procedures. Quantitative image 
analysis coupled to deep learning techniques has the potential to reduce this false positive rate. 
We conducted a computational analysis of 1449 low-dose CT studies drawn from the National 
Lung Screening Trial (NLST) cohort. We applied to this cohort our newly developed algorithm, 
DeepScreener, which is based on a novel deep learning approach. The algorithm, after the 
training process using about 3000 CT studies, does not require lung nodule annotations to 
conduct cancer prediction. The algorithm uses consecutive slices and multi-task features to 
determine whether a nodule is likely to be cancer, and a spatial pyramid to detect nodules at 
different scales.  We find that the algorithm can predict a patient’s cancer status from a volumetric 
lung CT image with high accuracy (78.2%, with area under the Receiver Operating Characteristic 
curve (AUC) of 0.858). Our preliminary framework ranked 16th of 1972 teams (top 1%) in the 
Data Science Bowl 2017 (DSB2017) competition, based on the challenge datasets. We report 
here the application of DeepScreener on an independent NLST test set. This study indicates that 
the deep learning approach has the potential to significantly reduce the false positive rate in lung 
cancer screening with low-dose CT scans. 
 
INTRODUCTION 
Lung cancer is the leading cause of cancer deaths and the second most common cancer in both 
men and women in the United States [1]. Because lung cancer is most often diagnosed at an 
advanced stage, the overall 5-year survival is poor (at 18%). Early detection is key to early 
intervention leading to improved survival. Compared with radiographs, low-dose CT can provide 
more detailed information and has been reported to lead to a 20% lower mortality rate [2]. Low-
dose CT has been recommended for lung cancer screening by the US Preventive Services Task 
Force [3].   
 
Lung cancer screening studies based on analysis by human experts have reported false positive 
rates as high as 58% [4]. This not only increases the cost for further tests and surgical procedures, 
but also causes unnecessary anxiety for patients and their families. The development of powerful 
computer-aided approaches for lung cancer early screening is critical to improve the current 
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clinical practice of CT imaging assessment. Computer-aided approaches are expected to produce 
automated solutions for early lung cancer screening and a reduced false positive rate in diagnosis. 
 
Numerous computer-aided approaches have been developed for chest image analysis in the past 
fifty years. Ginneken [5] reviews computer analysis in chest imaging and illustrates how the three 
types of approaches — rule-based image processing, machine learning, and deep learning — 
have been applied, and how deep learning is currently becoming the dominant approach with 
very promising results [6]. Most computational approaches to date such as [7-11], focus on finding 
and analyzing nodules in lung CT images. This dependency on predefined objects of interest 
requires detection and segmentation steps that are difficult to automate and limit the applicability 
of these approaches for automated screening.  
 
We have developed a deep learning approach we call DeepScreener, based on a convolutional 
neural network (CNN) model. The algorithm uses a pseudo-3-D model considering context 
information of consecutive slices of a participant’s lungs. DeepScreener is an automated end-to-
end solution for lung cancer screening that does not require a-priori lung nodule annotations. The 
preliminary framework of the algorithm ranked 16th of 1972 teams (top 1%) in the DSB2017 
competition [14]. We evaluated the algorithm’s ability to generalize beyond the competition 
dataset by applying it to an independent cohort drawn from the National Lung Screening Trial 
(NLST) [2].  
 
RESULTS 
DeepScreener achieves high accuracy for lung cancer detection on the NLST cohort. 
 
We tested the performance of DeepScreener using 1449 low-dose CT studies obtained from the 
Cancer Imaging Archive [16] with permission from the National Cancer Institute. DeepScreener 
was able to make predictions for 1359 of 1449 CT scans with an accuracy of 78.2%, AUC of 
0.858, the area under Precision-Recall curve (AUPRC) of 0.788, and log-loss of 0.484. Refer to 
Figure 1 for the ROC curve and the Precision-Recall curve resulting from this analysis. The 
algorithm correctly identified 148 of 432 positive examples (sensitivity 34.3%) and 915 of 927 
negative examples (specificity 98.7%). Refer to Table 1 for the complete set of validation metrics 
and performance details, and the discussion section for our analysis of these results. 
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We found that several of the images in our test cohort exhibited some kind of unusual defect. For 
example, some images contained uneven “slice spacing” — the spacing between slices along the 
superior/inferior axis was not consistent. If the spacing varied enough to suggest a “gap”, or 
missing slice, the image was rejected. We also noted that some images contained one or more 
“duplicate” slices — the pixels in the 2-D slice were identical to the pixels in another 2-D slice 
within the scan. In these cases, we dropped the duplicate slice in preprocessing. In total, 
DeepScreener rejected 90 CT studies due to inconsistencies. 
 
Evaluation Metrics. We used the following statistical criteria to test the performance of 
DeepScreener: Accuracy, sensitivity, specificity, AUC, the f1-score and LogLoss. 
Accuracy is defined as acc = $%&$''  where TP  represents the number of true positives, TN 
represents the number of true negatives, and N represents the total number of scans considered. 
Sensitivity is defined as sen = $%$%&.' where TP is the number of true positives and FN is the total 
number of false negative (i.e. missed positive) scans. Specificity is defined as spc = $'$'&.% where TN is the number of true negatives and FP is the number of false-positive scans. We use AUC to 
refer to the area under the receiver operating characteristic curve, which plots the true positive 
rate against the false positive rate under varying classification threshold values [22]. We use 
AUPRC to refer to the area under the Precision-Recall curve, which plots the trade-off between 
precision and recall (recall is synonymous with sensitivity). The f1-score is a measure of accuracy 
involving both precision and sensitivity [23], defined as 𝐹2 = 2 ⋅ %567898:;⋅<6;98=8>8=?%567898:;&<6;98=8>8=? 
where Precision = $%$%&.% . LogLoss is defined as LogLoss = − 2'∑ ['HI2 𝑦H ⋅ logL(𝑦NO) + (1 − 𝑦H) ⋅logL(1 − 𝑦NO)], where 𝑦NO  is the predicted probability of the image belonging to a patient with cancer, 𝑦H is 1 if the diagnosis is cancer, 0 otherwise, logL(⋅) is the natural (base 𝑒) logarithm. 
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Table 1: Validation metrics for DeepScreener and grt123 algorithms on the NLST cohort. 
Metric DeepScreener grt123 
Total 1359 1449 
# Positive 432 469 
# Negative 927 980 
AUC 0.858 0.885 
AUPRC 0.788 0.837 
Accuracy 0.782 0.821 
LogLoss 0.484 0.434 
f1-score 0.500 0.631 
Sensitivity 0.343 0.473 
Specificity 0.987 0.987 
# False Positives 12 13 
# False Negatives 284 247 
 
DeepScreener has performance comparable to the winning algorithm of DSB2017 on the 
NLST cohort.  
We compare the performance of our algorithm DeepScreener with the winning algorithm grt123 
of Data Science Bowl 2017 for lung cancer detection. We find on this NLST cohort of 1449 low-
dose CT scans, the performance of DeepScreener is very close to the performance of grt123. 
The algorithm, grt123, was able to process 1449 of the 1449 CT scans with accuracy of 82.1%, 
AUC of 0.885, area under Precision-Recall curve (AUPRC) of 0.837, and log-loss of 0.434. Refer 
to Figure 2 for the ROC curve and the Precision-Recall curve. The algorithm correctly identified 
222 of 469 positive examples (sensitivity 47.3%) and 967 of 980 negative examples (specificity 
98.7%). Refer to Table 1 for the performance details. DeepScreener achieved an AUC of 0.858, 
slightly lower than grt123. To determine whether the difference in performance was significant, 
we compared the Receiver Operating Characteristic curves for both methods using the DeLong 
method [24], with the null hypothesis that the difference in AUC for the two models is equal to 
zero. The test shows that with 𝑝 = 0.070 we cannot reject our null hypothesis to a confidence 
level of 𝛼 = 0.05, thus we conclude that there is no significant difference in performance between 
the two methods on the NLST cohort.  
SUMMARY AND DISCUSSION 
Computed tomography screening has been shown to aid in early detection of lung cancer in at 
risk patients, leading to reductions in lung cancer death rates [2]. Unfortunately, CT screening is 
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also associated with high rates of false-positive diagnoses. Currently most computer-aided 
diagnosis (CAD) tools focus on evaluating lung nodules, which must be identified a-priori, either 
by a radiologist or with an automated tool. Here we chose to instead focus on risk prediction at 
the patient level, taking into account information from the whole lung. Our approach could be 
combined with others to provide a layered strategy for identifying and diagnosing lung cancer. 
Our approach combines convolutional neural network models and an XGboost classifier to predict 
the presence of lung cancer at the whole-image level. We chose to test our strategy on low-dose 
CT scan data from the National Lung Cancer Screening Trial (NLST). To our knowledge, this is 
the first time a whole lung CNN-based classifier has been tested on this large NLST cohort.  
 
On the NLST cohort of 1449 low-dose CT scans, we tested our deep learning algorithm for 
predicting lung cancer status with whole low-dose CT scans of the patients. Our algorithm 
DeepScreener was able to make predictions with high accuracy, with an AUC of 0.858, and an 
AUPRC of 0.788. From the testing results on the NLST cohort, we anticipate deep learning 
algorithms can achieve a performance potentially comparable to human experts and radiologists 
for lung cancer prediction and detection with low-dose CT scans. Through training and learning 
from CT images of even a larger population, the approach will yield sensitive, stable, consistent 
and reliable lung cancer screening with the potential of reducing the human effort and cost of 
screening.  
 
The initial framework for DeepScreener was developed for the DSB2017 competition, and was 
optimized according to the performance metric used by the competition (minimizing log-loss) [14]. 
One of our goals for developing automated screening tools is to reduce the false-positive rate 
associated with lung screenings performed by radiologists. However, the particular metric chosen 
by the DSB2017 competition may have skewed the model too far in the direction of reducing false 
positives at the expense of missed cancers (false negative rate). In addition, the cohort we used 
for this validation procedure was selected to include cases where the original NLST study 
contained a likely “false negative” screen. We did this by querying for cases where the patient’s 
cancer diagnosis followed a negative screen and adding those cases to our query for patients 
who screened as “positive”. Thus, our testing cohort itself may be expected to elicit a higher-than-
normal false negative rate. More work needs be done to balance this trade-off to levels that are 
clinically acceptable. In evaluating both our competition model and the winning model against a 
previously-unseen set of challenging CT screening images, we gain some insight into the value 
of such competition models in real-world applications.  Our results hint that the choice of a 
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competition scoring metric may induce biases in the models that need to be addressed before 
wider application.  We note that our model had an accuracy (78.2%) and an AUC (0.858).  We 
examined the effect of modifying the decision threshold (which was at the default 0.5 for the 
results reported here) with respect to the model’s output predictions on NLST and found that a 
lower threshold would have improved the results.  A threshold setting of 0.29 would maximize the 
accuracy metric at 83.4%, and a threshold setting of 0.19 would maximize sum of sensitivity and 
specificity at 69.2% and 87.6% respectively. Obviously, any such tuning based on a-posteriori 
observations would need to be evaluated by re-training the model and performing an independent 
validation, but it suggests that training with an objective different than log-loss may be beneficial, 
as well as parameter tuning to guide the algorithm toward more balanced performance. In the 
future, we hope to further develop the model to decrease the number of missed positives, and 
also add visualization options to help make the model’s classification decisions interpretable for 
researchers and clinicians. These improvements will be necessary before tools such as these will 
be accepted into the clinical diagnostic tool set. 
 
MATERIAL AND METHOD 
Datasets for training, validation, and testing. We use the following datasets: (1) the LIDC/IDRI 
cohort data, (2) the LUNA16 Challenge data, (3) the DSB2017 Competition data, and (4) a subset 
of the NLST cohort data. Note that there are some overlaps between these datasets, and we have 
carefully considered this and tried to remove the overlaps between the training and evaluation 
datasets. 
 
The Lung Image Database Consortium image collection (LIDC/IDRI) [12] consists of diagnostic 
CT data sets with annotated lesions for 1018 participants. Each study includes images from a 
clinical thoracic CT scan and an associated XML file that records the results of a two-phase image 
annotation process performed by four experienced thoracic radiologists. The radiologists 
annotated each scan by marking regions of interest in three classes: "nodule ≥ 3mm", "nodule < 
3mm", and "non-nodule".  Each nodule in the "nodule ≥ 3mm" class was then given a malignancy 
score and a detailed segmentation. The LUNA16 Challenge [13] released a list of additional 
nodules, which were missed by expert readers who originally annotated the LIDC/IDRI data. 
 
The Kaggle Data Science Bowl 2017 [14] dataset is comprised of 2101 chest CT studies. Of the 
2101, 1595 were initially released in stage 1 of the challenge, with 1397 belonging to the training 
set and 198 belonging to the testing set. The remaining 506 were released in stage 2 as a final 
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testing set. Each CT study was labeled as ‘with cancer’ if the associated patient was diagnosed 
with cancer within one year of the scan, and ‘without cancer’ otherwise. Crucially, the location or 
size of nodules are not labeled. This data was partially drawn from the NLST cohort. Care was 
taken in selecting our test cohort to be independent, as explained below. 
 
We tested the performance of the algorithm using data from National Lung Screening Trial (NLST) 
(with permission of NCI). 1663 screens were selected for this study with 1000 negative screens 
and 663 positive screens. The ground truth labels for each study were defined as the presence 
or absence of a cancer diagnosis during the NLST trial period [2]. We eliminated 5 screens due 
to missing image data at the time point where the screen was marked as “positive”. An additional 
209 screens were eliminated due to an overlap with training data from DSB2017 (202), LIDC/IDRI 
(3), or both (4). 
 
To identify overlapping images, we used an image fingerprinting method based on comparing 
intensity histograms of selected slices from each scan in all three primary source cohorts 
(LIDC/IDRI, DSB2017, NLST). Note that LUNA16 is a subset of LIDC/IDRI. Fingerprints for 
individual slices were produced by loading the pixel values from the DICOM image representing 
the slice and transforming the pixel intensities to Hounsfield Units (HU). Then an intensity 
histogram containing 20 bins roughly centered in regions representing different tissue densities 
was generated. Bin boundaries were fixed to the following HU values: [−1024,−500,−300,−150,−125,−100,−80,−40,−2,0,20,40,60,80,100,125,150,300,500,1024,2048]
. Histograms were calculated in this way for each of the first and last ten slices of each scan, 
ordered by the Instance Number DICOM attribute. The histograms were combined into a 
fingerprint vector that was utilized for comparing the mean squared error (MSE) of all possible 
combinations of images from each dataset. This method was chosen to be both relatively 
computationally efficient and robust against possible changes made to images when migrating 
from their original datasets into the competition cohort (such as re-sampling voxel dimensions, 
reversing the superior/inferior axis, or missing/duplicated slices). We found no evidence of such 
changes; all overlaps we discovered had an MSE < 0.001, with a large gap between matches and 
non-matches (MSE > 200). The lowest scoring non-matches were examined visually to confirm 
that they were not modified versions of the same scans. 
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DeepScreener: a novel algorithm to predict lung cancer. DeepScreener provides an 
automated solution to predict whether a patient has lung cancer based on a low-dose screening 
CT study. Please refer to Figure 3 for an overview of the deep learning algorithm. 
 
Our training strategy can be summarized as follows. First, we trained the image analysis stage of 
the model for nodule identification using the images and radiologist annotations for nodules in the 
LIDC/IDRI cohort. We also included annotations for additional nodules released by the LUNA16 
Challenge. Then we trained the classification stage of the model for predicting lung cancer from 
CT data without a-priori nodule annotations. For this purpose, we used the DSB2017 Competition 
[14] stage one CT data for training, and the stage two CT data for validation. The classification 
stage was trained by minimizing log-loss with respect to the ground truth classifications provided 
by the DSB2017 competition. Finally, generalization testing of the algorithm was conducted with 
our own selected cohort of low-dose CT images from the NLST study, and reported here. 
 
In the following we describe the algorithm DeepScreener in detail, including how to train the CNN 
models and make predictions to identify patients with lung cancer using low-dose whole CT scans.  
 
Pseudo 3-D Model to Extract Consecutive Information across Slices. We view a patient CT 
scan as a 3-dimensional volume. For example, a typical chest CT scan is about 512 x 512 x N, 
where N is the number of slices. The resolution within the 2-D slices may be different than 
between slices. A standard convolutional network can only handle 2-D data, and the scan has to 
be processed as N individual slices of 512 x 512. Such slice-based processing loses almost all 
contextual information along the third dimension. For example, a blood vessel facing the z-
dimension (perpendicular to the image in an axial view orientation) appears as a sphere and might 
be mistaken for a small nodule. Note that a 3-D convolutional network could be used to handle 
the 3-D information, but a 3-D network has limitations. For example, compared with a 2-D model, 
a 3-D convolutional network has many more parameters and is therefore more difficult to train. 
Training a 3-D network typically requires a much larger training data set. Instead, we chose to 
use a pseudo-3-D model. Our approach takes advantage of the fact that an image can have 
multiple (typically 3) channels and encode neighboring slices as multiple channels of a single 
image. Specifically, for each slice processed, we use the slice itself as the “green” channel of the 
image, and add one slice above as the “blue” channel and once slice below as the “red” channel, 
each at a distance of 4mm; see Figure 4. 
   
 10 
 
Multi-Task Learning for Feature Extraction for Cancer Classification of the Detected 
Nodules. A segmentation network [15, 17] only produces a 2-dimensional shape for each nodule 
detected, and the shape boundary is typically blurry due to low decision confidence. It is possible 
to extract a few features, like area, average confidence and aspect ratio, but such features 
extracted solely based on a 2-D shape cannot capture all characteristics of a nodule that are 
visible to an expert viewing the original volumetric image. 
 
The LIDC/IDRI dataset [2] provides expert annotation of about 1000 CT scans. In addition to 
nodule contours, a series of descriptive features are provided for each nodule, e.g. subtlety, 
sphericity, lobulation, etc. We designed a multi-task convolutional network to simultaneously fit 9 
such features (see Figure 5): subtlety, sphericity, margin, lobulation, spiculation, texture, 
malignancy, calcification-1 and calcification -2. We do not use all of the available categorical 
features provided by LIDC/IDRI because we found some to be redundant. We split the categorical 
feature “calcification” into two binary features. This feature extraction network can increase the 
information available to the subsequent machine-learning module, i.e. gradient boosting decision 
trees (GBDT) [18] and improve classification stage accuracy. 
 
Feature Pooling with Spatial Pyramid to Detect Tumors of Different Scales. After 
segmentation, nodule detection and feature extraction, we convert each CT volume into a list of 
nodule location (x, y, z) and features (size, subtlety, etc). For subsequent learning with GBDT, we 
need to pool this list of variable length into a vector of fixed number of dimensions. We apply the 
spatial pyramid approach [19] for such pooling.  Specifically, we define a fixed number of regions 
with overlap, by partitioning the 3-D volume in multiple ways. The image in Figure 6 shows two 
sample partitions, each with four regions. For each region, we use the feature vector of the largest 
nodule as the region feature vector, or zeros if no nodule is detected within this region.  We then 
concatenate the feature vectors from all regions to produce a feature vector representing the full 
CT volume. Even though the spatial pyramid generates a holistic representation of a full CT scan, 
we can also use it to represent an individual nodule, simply by removing all other nodules detected 
from the same CT scan. In this way we can apply the GBDT classifier model to assign a 
confidence score for each individual nodule. The patient-level classifier utilizes this ensemble of 
scores to produce a single confidence score. 
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FIGURES 
 
Figure 1: Performance characteristics for the DeepScreener algorithm applied to the selected 
NLST subset (N=1359). (a) Receiver operating characteristic curve. Area under the ROC curve 
is 0.858. (b) Precision-Recall curve. Area under the PR curve is 0.788. 
 
 
Figure 2: Performance characteristics for the grt123 algorithm applied to the selected NLST 
subset (N=1449). (a) Receiver operating characteristic curve. Area under the ROC curve is 
0.885. (b) Precision-Recall curve. Area under the PR curve is 0.837. 
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Figure 3: DeepScreener takes a 3-D chest CT image as input and uses a classification model 
based on convolutional neural networks and gradient boosting decision trees to output a 
prediction (in the range [0,1]) representing the likelihood that the patient has lung cancer. 
 
 
 
 
Figure 4: Pseudo-3-D image produced by “stacking” three individual slices from the 3-D CT 
image into the blue (B), green (G), and red (R) color channels of a 2-D 3-channel image. 
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Figure 5: Multi-task convolutional network simultaneously computes 9 features as annotated in 
the LIDC/IDRI cohort: subtlety, sphericity, margin, lobulation, spiculation, texture, malignancy, 
calcification-1 and calcification-2. 
 
 
 
 
 
Figure 6: Example of two partitioning schemes: Each partitioning scheme defines four regions, 
which may overlap. 
 
